Implanting a ventricular assist device (VAD), or heart pump, is one way the highly skilled interventional cardiologists and surgeons at Loyola Medicine treat patients with heart failure. A VAD is a mechanical pump that helps support heart function and blood flow.

University of Utah Health’s Mechanical Circulatory Support Program uses the most advanced and reliable ventricular assist devices (VADs) available for patients . Features of each LVAD may be different depending on the manufacturer. Talk to your clinician about which LVAD might be right for you. Note: An LVAD is a type of VAD.

Jul 29, 2022 · In 2008, the US Food and Drug Administration (FDA) cleared the use of the first Impella device, a percutaneous ventricular assist device (PVAD), for short-term mechanical circulatory support (MCS) in severe left ventricular failure. 1 Subsequently, the PROTECT II study (A Prospective, Multi-Center, Randomized Controlled Trial of the IMPELLA ...

Jan 22, 2024 · A new percutaneous left ventricular assist device (pVAD), the Magenta Elevate, may offer a next step with with the smallest catheter size yet to be used in a first-in-human trial. The Elevate uses a 10 French catheter, while the current standard of …

VenstraMedical is a medical device startup bringing an advanced percutaneous ventricular assist device (pVAD) capable of pumping 7 liter/min at 60mmHg of pressure in a collapsible, 9F delivery approach.

Aug 20, 2019 · Issue: Interventional cardiologists have been employing the use of percutaneous Ventricular Assist Devices (PVADs) to provide hemodynamic support in patients undergoing high-risk percutaneous coronary intervention (PCI) even in the absence of cardiogenic shock.

Jul 29, 2022 · Percutaneous ventricular assist devices (PVADs) have been replacing intra-aortic balloon pumps for hemodynamic support during percutaneous coronary intervention (PCI), even though data supporting a benefit for hard clinical end points remain limited.

At Narwhal Medical, our mission is to design and manufacture the smallest and most advanced pVAD. With our cutting-edge technologies and world-class expertise, we are poised to revolutionize the blood pump industry.

Management of patients with pVAD in the ICU requires the availability of an adequately trained personnel in critical care medicine. Patients must receive advanced hemodynamic monitoring with pulmonary artery catheter

BACKGROUND: Percutaneous ventricular assist devices (PVADs) have been replacing intra-aortic balloon pumps for hemodynamic support during percutaneous coronary intervention (PCI), even though data supporting a benefit for hard clinical end points remain limited.